Adverse effects in neonates exposed to SSRIs and SNRI in late gestation

Canadian Journal of Clinical Pharmacology

Volumn 16, Issue 1, 2009, Pages

  Koren, Gideon ^a   Boucher, Nina ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; ADRENERGIC RECEPTOR AFFECTING AGENT;

ARTICLE; DRUG BLOOD LEVEL; HUMAN; IRRITABILITY; MATERNAL MORBIDITY; MUSCLE RIGIDITY; PERSISTENT PULMONARY HYPERTENSION; PRENATAL DRUG EXPOSURE; PUERPERAL DEPRESSION; RESPIRATORY DISTRESS; RISK BENEFIT ANALYSIS; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; TREMOR; CHEMICALLY INDUCED DISORDER; DEPRESSION; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; NEWBORN; NEWBORN DISEASE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADRENERGIC UPTAKE INHIBITORS; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 61949299006     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmcol 2008; 1: 15-26.
2. Koren G, Matsui D, Einarson A, Knoppert D, Steiner M. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? CMAJ 2005; 172: 1457-9.
3. Knoppert DC, Nimkar R, Principi T, Yuen D. Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels. Ther Drug Monit 2006; 28: 5-7.
4. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354: 579-87.
5. Kallen B, Olausson PO. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2008; 17: 801-6.
6. Fornaro E, Li D, Pan J, Belik J. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am J Respir Crit Care Med 2007; 176: 1035-40.